Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.890
-0.100 (-5.03%)
At close: Jun 5, 2026, 4:00 PM EDT
1.880
-0.010 (-0.53%)
After-hours: Jun 5, 2026, 7:00 PM EDT
Annovis Bio Employees
Annovis Bio had 7 employees as of December 31, 2025. The number of employees decreased by 8 or -53.33% compared to the previous year.
Employees
7
Change (1Y)
-8
Growth (1Y)
-53.33%
Revenue / Employee
n/a
Profits / Employee
-$4,122,028
Market Cap
80.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -8 | -53.33% | 7 | 0 |
| Dec 31, 2024 | 15 | -1 | -6.25% | 8 | 7 |
| Dec 31, 2023 | 16 | 11 | 220.00% | 6 | 10 |
| Dec 31, 2022 | 5 | 2 | 66.67% | 5 | 0 |
| Dec 31, 2021 | 3 | 1 | 50.00% | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Heron Therapeutics | 128 |
| Rani Therapeutics Holdings | 71 |
| Aardvark Therapeutics | 40 |
| eXoZymes | 32 |
| NeurAxis | 24 |
| MAIA Biotechnology | 13 |
| ProMIS Neurosciences | 11 |
ANVS News
- 12 days ago - Annovis Bio regains NYSE listing compliance - TheFly
- 12 days ago - Annovis Bio Regains NYSE Listing Compliance - GlobeNewsWire
- 18 days ago - Annovis Bio 7.9M share Spot Secondary priced at $1.90 - TheFly
- 18 days ago - Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - GlobeNewsWire
- 19 days ago - Annovis Bio announces common stock and warrants offering, no amount given - TheFly
- 19 days ago - Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants - GlobeNewsWire
- 23 days ago - Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 23 days ago - Annovis Bio Quarterly report: Q1 2026 - Filings